Metabolic Enzyme/Protease
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 26A012 | GLO1 inhibitor-Compound 60 | 2314467-61-1 | ≧98.0% |  |
| GLO1 inhibitor-Compound 60 is a novel potent Glyoxalase 1 (GLO1) inhibitor. | ||||
| 26A082 | Mutant IDH1/NAMPT-IN-1 | 3040122-14-0 | ≧98.0% |  |
| Mutant IDH1/NAMPT-IN-1 ( compound 23h ) has excellent and balanced inhibitory activit | ||||
| 26A028 | NSC624206 | 13116-77-3 | ≧98.0% |  |
| NSC624206 is a Ub E1 inhibitor that specifically inhibits thioester bond formation be | ||||
| 26A038 | Pantothenate kinase-IN-2 | 902614-04-4 | ≧98.0% |  |
| Pantothenate kinase-IN-2 is a pantothenate kinase inhibitor with IC50 values of 92 nM | ||||
| 26A039 | PZ-3022 | 2170608-85-0 | ≧98.0% |  |
| PZ-3022 is an allosteric PanK activator that counteracts C3-CoA inhibition. | ||||
| 26A040 | Claziprotamidum ( Claziprotamide ; BBP-671 ) | 2361124-03-8 | ≧98.0% | _2361124-03-8.png) |
| Claziprotamidum ( Claziprotamide ; BBP-671 ) is a potent, orally active, and blood-br | ||||
| 26A041 | Pantothenate kinase-IN-3 (also known as Compound 21) | ≧98.0% | .png) | |
| Pantothenate kinase-IN-3 (also known as Compound 21,https://doi.org/10.1021/acs.jmedc | ||||
| 26A060 | Linvemastat (Synonyms: FP-020) | 2389060-50-6 | ≧98.0% | _2389060-50-6.png) |
| Linvemastat (FP-020) is a highly potent and selective oral MMP-12 inhibitor. | ||||
| 26A061 | Osivelotor (Synonyms: GBT-601; GBT-021601) | 2417955-18-9 | ≧98.0% |  |
| Osivelotor (Synonyms: GBT-601; GBT-021601) is a next-generation sickle hemoglobin (Hb | ||||
| 26A086 | Aderamastat ( Synonyms: FP-025 ) | 877176-23-3 | 98% Min. | _877176-23-3.png) |
| Aderamastat (FP-025) is an oral, selective, non-hydroxamate-based, non-competitive in | ||||
| 26A084 | GDD-261 | 3137699-54-5 | ≧98.0% |  |
| GDD-261 is an orally active, allosteric inhibitor of phosphoglycerate dehydrogenase ( | ||||